Search
for
Sort by
Research 931–960 of 1000+
- The spectrum of hair loss in patients with mycosis fungoides and Sézary syndrome
- Dermoscopy: what's new?
- Disease modifying agent related skin reactions in multiple sclerosis: prevention, assessment, and management
- Trichoscopy in Hair Shaft Disorders
- Alternative uses of dermoscopy in daily clinical practice: An update
- Syphilis: A great imitator
- Madarosis
- Dermoscopy Research—An Update
- Differential diagnosis of hair loss in children. Differentialdiagnose des Haarausfalls bei Kindern
- Skin disorders in elderly subjects
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Alopecia in Association with Malignancy: A Review
- Guidelines for the Use of Acitretin in Psoriasis
- Interventions for morphea
- Group IID, IIE, IIF and III secreted phospholipase A2s
- Aromatic plants as cosmeceuticals: benefits and applications for skin health
- Cicatricial Alopecia Research Foundation meeting, May 2016: Progress towards the diagnosis, treatment and cure of primary cicatricial alopecias
- Contraception and the dermatologist
- Change of the diagnostic distribution in applicants to dermatology after COVID ‐19 pandemic: What it whispers to us?
- Alopecia in Children: The Most Common Causes
- Dermoscopy Update: Review of its Extradiagnostic and Expanding Indications and Future Prospects
- Vertical vs. transverse sections of scalp biopsy specimens: a pilot study on the comparison of the diagnostic value of two techniques in alopecia
- Laser Resurfacing
- Systemic causes of hair loss
- Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects
- Adverse cutaneous reactions to chemotherapeutic agents and cytokine therapy
- Ethnic Hair Disorders
- Cutaneous reactions to targeted therapies in children with CNS tumors: A cross‐sectional study
- Management of Cutaneous and Extracutaneous Side Effects of Smoothened Inhibitor Therapy for Advanced Basal Cell Carcinoma
- Skin diseases in consequence of endocrine alterations